Inhibition of mitotic clonal expansion mediates fisetin-exerted prevention of adipocyte differentiation in 3T3-L1 cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of mitotic clonal expansion mediates fisetin-exerted prevention of adipocyte differentiation in 3T3-L1 cells
Authors
Keywords
Fisetin, Adipocyte differentiation, 3T3-L1, Mitotic clonal expansion, Cell cycle
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 36, Issue 11, Pages 1377-1384
Publisher
Springer Nature
Online
2013-08-05
DOI
10.1007/s12272-013-0226-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fisetin regulates obesity by targeting mTORC1 signaling
- (2013) Chang Hwa Jung et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells
- (2012) Ki Young Jang et al. CANCER LETTERS
- Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB
- (2012) Fera Y. Goh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway
- (2011) Tsung-Ho Ying et al. ARCHIVES OF TOXICOLOGY
- Modulatory effects of fisetin, a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal tissues in streptozotocin-induced diabetic rats
- (2011) Gopalan Sriram Prasath et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fisetin, a novel flavonol attenuates benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice
- (2011) Nagaiya Ravichandran et al. FOOD AND CHEMICAL TOXICOLOGY
- Immunosuppressive Effects of Fisetin in Ovalbumin-Induced Asthma through Inhibition of NF-κB Activity
- (2011) Mei-Yao Wu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Dynamics of human adipose lipid turnover in health and metabolic disease
- (2011) Peter Arner et al. NATURE
- Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes
- (2011) Pamela Maher et al. PLoS One
- Fisetin, a Dietary Flavonoid, Induces Cell Cycle Arrest and Apoptosis through Activation of p53 and Inhibition of NF-Kappa B Pathways in Bladder Cancer Cells
- (2010) Jing Li et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin
- (2009) Do Y. Lim et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Apoptosis by dietary agents for prevention and treatment of prostate cancer
- (2009) Naghma Khan et al. ENDOCRINE-RELATED CANCER
- Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-κB
- (2009) Imtiyaz Murtaza et al. INTERNATIONAL JOURNAL OF CANCER
- Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells
- (2009) Chi-Sheng Chien et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Rehmannia inhibits adipocyte differentiation and adipogenesis
- (2008) Lin Jiang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF- B-signaling pathways
- (2008) Y. Suh et al. CARCINOGENESIS
- Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells
- (2008) Naghma Khan et al. CARCINOGENESIS
- Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models
- (2008) Jae-Dong Lee et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started